Global Tissue Diagnostics Market, By Product (Consumables, Instruments), Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, Other Diseases), End User (Hospitals, Pharmaceutical Companies, Research Laboratories, Diagnostic Centers, Ambulatory Surgical Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Tissue Diagnostics Market
Tissue diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 7.96 billion by 2028 and will grow at a CAGR of 7.70% in the above mentioned forecast period.
Tissue diagnostics is rising as a significant field of diagnostics research as tissue samples can elucidate different aspects of different biological conditions. Particularly in the field of cancer diagnostics and analysis, tissue diagnostics have played a major role as it has helped scientists and researchers to recognize the presence of cancer upon probing the tissue samples.
The rapidly developing infrastructure for cancer diagnosis is amongst the important factors intensifying the growth and demand of tissue diagnostics market. In addition, the increasing incidence rate of cancer, associated with rising incidence of chronic diseases in developed and developing countries is also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the various recommendations for cancer screening as well as rising healthcare expenditure are also enhancing the growth of the market. Likewise, the constant development in equipment used for tissue diagnostics along with growing health awareness amongst the general population and availability of reimbursements are also lifting the market growth in the above mentioned forecast period. The increasing demand for personalized medicines and growing number of clinical trials pertaining to cancer drugs will further accelerate the expansion of the tissue diagnostics market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the high degree of consolidation and strict regulatory requirements will curb the growth of the tissue diagnostics market; whereas the lack of infrastructure and low awareness in middle- and low- income countries as well as the availability of refurbished products have the potential to challenge the growth of the tissue diagnostics market.
This tissue diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on tissue diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Tissue Diagnostics Market Scope and Market Size
Tissue diagnostics market is segmented on the basis of product, technology, disease and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the tissue diagnostics market is segmented into consumables and instruments. Consumables have further been segmented into antibodies, kits, reagents and probes. Instruments have further been segmented into slide-staining systems scanners tissue-processing systems and others.
- On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow management and special staining.
- Based on disease, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer and other diseases.
- The end user segment of tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, diagnostic centers, ambulatory surgical centers and others.
Tissue Diagnostics Market Country Level Analysis
Tissue diagnostics market is analyzed and market size insights and trends are provided by country, product, technology, disease and end user as referenced above.
The countries covered in the tissue diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the tissue diagnostics market owing to the strong presence of numerous public programs aims to reduce cancer incidence and high demand for cancer diagnosis supplements within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rapid increase in number of patients suffering from chronic diseases and rise in government initiatives for the development of healthcare facilities in this particular region.
The country section of the tissue diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Tissue diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tissue diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tissue diagnostics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Tissue Diagnostics Market Share Analysis
Tissue diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to tissue diagnostics market.
The major players covered in the tissue diagnostics market report are F. Hoffmann-La Roche Ltd, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies Inc., Merck KGaA, Sakura Finetek Japan Co. Ltd., BD, QIAGEN, Bio SB, BioGenex., Abcam plc., Cell Signaling Technology, Inc., Koninklijke Philips N.V., The Menarini Group, Enzo Life Sciences, Inc., Zenalux Biomedical, Inc., 3DHISTECH Ltd., Lunaphore Technologies, Biocare Medical, LLC., Cernostics, and Genomic Health among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
